Aarhus University Seal / Aarhus Universitets segl

Peter Vedsted

Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership) : do they contribute to differences in cancer survival? / Forbes, L J L; Simon, A E; Warburton, F; Boniface, D; Brain, K E; Dessaix, A; Donnelly, C; Haynes, K; Hvidberg, L; Lagerlund, M; Lockwood, G; Tishelman, C; Vedsted, P; Vigmostad, M N; Ramirez, A J; Wardle, J; The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member).

I: B J C, 2013.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Forbes, LJL, Simon, AE, Warburton, F, Boniface, D, Brain, KE, Dessaix, A, Donnelly, C, Haynes, K, Hvidberg, L, Lagerlund, M, Lockwood, G, Tishelman, C, Vedsted, P, Vigmostad, MN, Ramirez, AJ, Wardle, J & The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member) 2013, 'Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?', B J C. https://doi.org/10.1038/bjc.2012.542

APA

Forbes, L. J. L., Simon, A. E., Warburton, F., Boniface, D., Brain, K. E., Dessaix, A., Donnelly, C., Haynes, K., Hvidberg, L., Lagerlund, M., Lockwood, G., Tishelman, C., Vedsted, P., Vigmostad, M. N., Ramirez, A. J., Wardle, J., & The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member) (2013). Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? B J C. https://doi.org/10.1038/bjc.2012.542

CBE

Forbes LJL, Simon AE, Warburton F, Boniface D, Brain KE, Dessaix A, Donnelly C, Haynes K, Hvidberg L, Lagerlund M, Lockwood G, Tishelman C, Vedsted P, Vigmostad MN, Ramirez AJ, Wardle J, The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member). 2013. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?. B J C. https://doi.org/10.1038/bjc.2012.542

MLA

Vancouver

Author

Forbes, L J L ; Simon, A E ; Warburton, F ; Boniface, D ; Brain, K E ; Dessaix, A ; Donnelly, C ; Haynes, K ; Hvidberg, L ; Lagerlund, M ; Lockwood, G ; Tishelman, C ; Vedsted, P ; Vigmostad, M N ; Ramirez, A J ; Wardle, J ; The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member). / Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership) : do they contribute to differences in cancer survival?. I: B J C. 2013.

Bibtex

@article{8e713b9b3cf8484387ec9094d64bb088,
title = "Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?",
abstract = "Background:There are wide international differences in 1-year cancer survival. The UK and Denmark perform poorly compared with other high-income countries with similar health care systems: Australia, Canada and Sweden have good cancer survival rates, Norway intermediate survival rates. The objective of this study was to examine the pattern of differences in cancer awareness and beliefs across these countries to identify where these might contribute to the pattern of survival.Methods:We carried out a population-based telephone interview survey of 19 079 men and women aged 50 years in Australia, Canada, Denmark, Norway, Sweden and the UK using the Awareness and Beliefs about Cancer measure.Results:Awareness that the risk of cancer increased with age was lower in the UK (14%), Canada (13%) and Australia (16%) but was higher in Denmark (25%), Norway (29%) and Sweden (38%). Symptom awareness was no lower in the UK and Denmark than other countries. Perceived barriers to symptomatic presentation were highest in the UK, in particular being worried about wasting the doctor's time (UK 34%; Canada 21%; Australia 14%; Denmark 12%; Norway 11%; Sweden 9%).Conclusion:The UK had low awareness of age-related risk and the highest perceived barriers to symptomatic presentation, but symptom awareness in the UK did not differ from other countries. Denmark had higher awareness of age-related risk and few perceived barriers to symptomatic presentation. This suggests that other factors must be involved in explaining Denmark's poor survival rates. In the UK, interventions that address barriers to prompt presentation in primary care should be developed and evaluated.British Journal of Cancer advance online publication, 31 January 2013; doi:10.1038/bjc.2012.542 www.bjcancer.com.",
author = "Forbes, {L J L} and Simon, {A E} and F Warburton and D Boniface and Brain, {K E} and A Dessaix and C Donnelly and K Haynes and L Hvidberg and M Lagerlund and G Lockwood and C Tishelman and P Vedsted and Vigmostad, {M N} and Ramirez, {A J} and J Wardle and {The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member)} and Pedersen, {Anette Fischer}",
year = "2013",
doi = "10.1038/bjc.2012.542",
language = "English",
journal = "B J C",
issn = "0007-0920",
publisher = "Nature Publishing Group",

}

RIS

TY - JOUR

T1 - Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership)

T2 - do they contribute to differences in cancer survival?

AU - Forbes, L J L

AU - Simon, A E

AU - Warburton, F

AU - Boniface, D

AU - Brain, K E

AU - Dessaix, A

AU - Donnelly, C

AU - Haynes, K

AU - Hvidberg, L

AU - Lagerlund, M

AU - Lockwood, G

AU - Tishelman, C

AU - Vedsted, P

AU - Vigmostad, M N

AU - Ramirez, A J

AU - Wardle, J

AU - The International Cancer Benchmarking Partnership Module 2 Working Group (Anette Fischer Pedersen, member)

AU - Pedersen, Anette Fischer

PY - 2013

Y1 - 2013

N2 - Background:There are wide international differences in 1-year cancer survival. The UK and Denmark perform poorly compared with other high-income countries with similar health care systems: Australia, Canada and Sweden have good cancer survival rates, Norway intermediate survival rates. The objective of this study was to examine the pattern of differences in cancer awareness and beliefs across these countries to identify where these might contribute to the pattern of survival.Methods:We carried out a population-based telephone interview survey of 19 079 men and women aged 50 years in Australia, Canada, Denmark, Norway, Sweden and the UK using the Awareness and Beliefs about Cancer measure.Results:Awareness that the risk of cancer increased with age was lower in the UK (14%), Canada (13%) and Australia (16%) but was higher in Denmark (25%), Norway (29%) and Sweden (38%). Symptom awareness was no lower in the UK and Denmark than other countries. Perceived barriers to symptomatic presentation were highest in the UK, in particular being worried about wasting the doctor's time (UK 34%; Canada 21%; Australia 14%; Denmark 12%; Norway 11%; Sweden 9%).Conclusion:The UK had low awareness of age-related risk and the highest perceived barriers to symptomatic presentation, but symptom awareness in the UK did not differ from other countries. Denmark had higher awareness of age-related risk and few perceived barriers to symptomatic presentation. This suggests that other factors must be involved in explaining Denmark's poor survival rates. In the UK, interventions that address barriers to prompt presentation in primary care should be developed and evaluated.British Journal of Cancer advance online publication, 31 January 2013; doi:10.1038/bjc.2012.542 www.bjcancer.com.

AB - Background:There are wide international differences in 1-year cancer survival. The UK and Denmark perform poorly compared with other high-income countries with similar health care systems: Australia, Canada and Sweden have good cancer survival rates, Norway intermediate survival rates. The objective of this study was to examine the pattern of differences in cancer awareness and beliefs across these countries to identify where these might contribute to the pattern of survival.Methods:We carried out a population-based telephone interview survey of 19 079 men and women aged 50 years in Australia, Canada, Denmark, Norway, Sweden and the UK using the Awareness and Beliefs about Cancer measure.Results:Awareness that the risk of cancer increased with age was lower in the UK (14%), Canada (13%) and Australia (16%) but was higher in Denmark (25%), Norway (29%) and Sweden (38%). Symptom awareness was no lower in the UK and Denmark than other countries. Perceived barriers to symptomatic presentation were highest in the UK, in particular being worried about wasting the doctor's time (UK 34%; Canada 21%; Australia 14%; Denmark 12%; Norway 11%; Sweden 9%).Conclusion:The UK had low awareness of age-related risk and the highest perceived barriers to symptomatic presentation, but symptom awareness in the UK did not differ from other countries. Denmark had higher awareness of age-related risk and few perceived barriers to symptomatic presentation. This suggests that other factors must be involved in explaining Denmark's poor survival rates. In the UK, interventions that address barriers to prompt presentation in primary care should be developed and evaluated.British Journal of Cancer advance online publication, 31 January 2013; doi:10.1038/bjc.2012.542 www.bjcancer.com.

U2 - 10.1038/bjc.2012.542

DO - 10.1038/bjc.2012.542

M3 - Journal article

C2 - 23370208

JO - B J C

JF - B J C

SN - 0007-0920

ER -